396
Participants
Start Date
May 13, 2023
Primary Completion Date
October 4, 2024
Study Completion Date
October 4, 2024
APSCTC
APSCTC + Toragesic® placebo + Tramal® placebo
Toragesic®
APSCTC placebo + Toragesic® + Tramal® placebo
Tramal®
APSCTC placebo + Toragesic® placebo + Tramal®
Azidus Brasil Pesquisa Científica e Desenvolvimento Ltda., Valinhos
Lead Sponsor
Apsen Farmaceutica S.A.
INDUSTRY